𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new NF-κB inhibitor based on the amino-epoxyquinol core of DHMEQ

✍ Scribed by Tsuyoshi Saitoh; Chika Shimada; Masatoshi Takeiri; Mitsuhiro Shiino; Shigeru Ohba; Rika Obata; Yuichi Ishikawa; Kazuo Umezawa; Shigeru Nishiyama


Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
899 KB
Volume
20
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

✦ Synopsis


The amino-epoxyquinols 6a and 6b were synthesized as soluble derivatives of an NF-κB inhibitor DHMEQ (1). In spite of the opposite configuration from 1, 6b rather than 6a affected the deactivation of NF-κB, based on NO secretion and MALDI-TOF MS analysis. It was indicated that 6b inhibited the activation by different manner from that of 1.


📜 SIMILAR VOLUMES


Effects of a novel NF-κB inhibitor, dehy
✍ Hong-ying Ruan; Muneyuki Masuda; Aya Ito; Kazuo Umezawa; Torahiko Nakashima; Ryu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Background: Recent studies provide evidence that the constitutive activation of nuclear factor-kappa b, nf-kappab plays a critical role in enhancing the growth of several types of malignancies, including head and neck squamous cell carcinoma (hnscc). ## Methods: In this study, we examined the

A New Series of M3 Muscarinic Antagonist
✍ O. Diouf; S. Gadeau; F. Chelle; M. Gelbcke; P. Talaga; B. Christophe; M. Gillard 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 113 KB

A New Series of M3 Muscarinic Antagonists Based on the 4-Amino-piperidine Scaffold. -Twenty-five new N,N-disubstituted 4-aminopiperidines are synthesized by chemical modulation of aminopiperidine bearing a phenyl and a benzoyl group at the amino group. The main pharmacophoric pattern which allows a